Literature DB >> 4625922

The inactivation of bradykinin in the pulmonary circulation of isolated lungs.

V A Alabaster, Y S Bakhle.   

Abstract

1. The isolated lungs of guinea-pigs, rats and dogs, perfused with Krebs bicarbonate solution via the pulmonary artery, inactivated 95, 98 and 99% respectively of the bradykinin infused through them.2. This inactivation process was not inhibited by 2-mercaptoethanol (1 mM) or EDTA (500 muM).3. The inactivation was inhibited by 2:3-dimercaptopropanol (100 muM), N-ethylmaleimide (100 muM), and several of the bradykinin potentiating peptides from Bothrops jararaca, in both natural and synthetic forms.4. The effect of these compounds, 2-mercaptoethanol, EDTA, 2:3-dimercaptopropanol, N-ethylmaleimide and Bothrops peptides on the pulmonary bradykininase activity is the same as their effect on pulmonary angiotensin I converting enzyme.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625922      PMCID: PMC1666127          DOI: 10.1111/j.1476-5381.1972.tb08084.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

Authors:  S H FERREIRA
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Characteristics of the angiotensin I converting enzyme from dog lung.

Authors:  Y S Bakhle; A M Reynard
Journal:  Nat New Biol       Date:  1971-02-10

3.  Non-identity between pulmonary bradykininase and converting-enzyme activity.

Authors:  H W Scholz; P Biron
Journal:  Rev Can Biol       Date:  1969-09

4.  Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom.

Authors:  S H Ferreira; D C Bartelt; L J Greene
Journal:  Biochemistry       Date:  1970-06-23       Impact factor: 3.162

5.  The detection and estimation of bradykinin in the circulating blood.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-03

6.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

7.  Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.

Authors:  Y S Bakhle
Journal:  Nature       Date:  1968-11-30       Impact factor: 49.962

8.  Pulmonary extractionof bradykinin and eledoisin.

Authors:  P Biron
Journal:  Rev Can Biol       Date:  1968-03

9.  Inactivation of bradykinin in the pulmonary circulation.

Authors:  J W Ryan; J Roblero; J M Stewart
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

10.  Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).

Authors:  H Y Yang; E G Erdös; Y Levin
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

View more
  7 in total

1.  Inhibition of the pulmonary inactivation of prostaglandins in vivo by di-4-phloretin phosphate.

Authors:  D J Crutchley; P J Piper
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

2.  Proceedings: The nature of the bradykinin inactivating system in isolated lungs.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

3.  Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

4.  The bradykininase activities of extracts of dog lung.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

Review 5.  The biochemical properties of the pulmonary circulation.

Authors:  J A Pang; D M Geddes
Journal:  Lung       Date:  1981       Impact factor: 2.584

6.  Prostaglandin inactivation in guinea-pig lung and its inhibition.

Authors:  D J Crutchley; P J Piper
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

7.  Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.

Authors:  T Griesbacher; F Lembeck; A Saria
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.